COMMUNIQUÉS West-GlobeNewswire

miRagen Therapeutics and The Leukemia & Lymphoma Society® Enter Into an Agreement to Facilitate the Development of Cobomarsen in Cutaneous T-Cell Lymphoma

06/08/2018 - 13:00

BOULDER, Colo. and RYE BROOK, N.Y., Aug. 06, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted [...]

Cara Therapeutics Appoints Christopher A. Posner to Board of Directors

06/08/2018 - 13:00

STAMFORD, Conn., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets

06/08/2018 - 13:00

NORTHVALE, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Antares Pharma Enters Into Development Agreement With Pfizer Inc.

06/08/2018 - 13:00

EWING, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that it has entered into an agreement with Pfizer Inc. (“Pfizer”) to develop a combination drug device [...]

Neuralstem Appoints Jim Scully as Interim Chief Executive Officer

06/08/2018 - 13:00

William Oldaker Expands Role and is Named Chairman of the Board GERMANTOWN, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system [...]

iTeos Therapeutics to Participate in Upcoming U.S. Conferences in August

06/08/2018 - 13:00

iTeos Therapeutics to Participate in Upcoming U.S. Conferences in August Gosselies, Belgium – August 6, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced that [...]

Complete Response Letter Issued for REMOXY™

06/08/2018 - 13:00

- Corporate Reorganization Expected Shortly - AUSTIN, Texas, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today announced it had received a Complete Response Letter (CRL) from the U.S. Food [...]

Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations Form Partnership to Develop a Novel Gene Therapy Treatment for Cystic Fibrosis

06/08/2018 - 13:00

Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations Form Partnership to Develop a Novel Gene Therapy Treatment for Cystic Fibrosis Oxford, UK – 6 August 2018: [...]

Angiochem Announces Special Protocol Assessment (SPA) with US Food and Drug Administration (FDA)

06/08/2018 - 13:00

MONTREAL, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Angiochem Inc. (“Angiochem”) announced today that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on [...]

Unum Therapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on August 13, 2018 at 5:00 P.M. ET

06/08/2018 - 13:00

CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]

Bellicum Pharmaceuticals Appoints Dr. Thierry Darcis as General Manager of Europe to Lead the Anticipated Launch of BPX-501

06/08/2018 - 13:00

HOUSTON, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Summit Therapeutics to Present at the Canaccord Genuity Growth Conference

06/08/2018 - 13:00

OXFORD, United Kingdom and CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT) (AIM: SUMM) announces that Glyn Edwards, Chief Executive Officer, will present at the Canaccord [...]

T2 Biosystems Reports Granting of Inducement Awards

06/08/2018 - 13:00

LEXINGTON, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

International Stem Cell Corporation Developed 3D Liver Structures

06/08/2018 - 13:00

CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]

AnaptysBio to Present at the 2018 Wedbush PacGrow Healthcare Conference

06/08/2018 - 12:30

SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, [...]

U.S. FDA Grants Fast Track Designation for BioCryst’s BCX7353

06/08/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]

C-RAD Web Presentation Half-Year Report 2018

06/08/2018 - 11:00

Presentation of the report for the first half of the fiscal year 2018: Date: Friday August 17, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-Year Report 2018 Procedure: Please register online through the [...]

ASLAN Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

06/08/2018 - 10:05

SINGAPORE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]

Bio-on chooses Siemens control and supervisory systems to develop Industry 4.0 in the bioplastic sector

06/08/2018 - 08:39

Press Joint press release Siemens and Bio-On Milan, 06 August 2018 Bio-on's new production hub has begun producing bioplastic with a Siemens control and supervisory system The new Bio-on plant was created innovatively, [...]